Skip to content
medxy logo

Medxy AI

  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
Tailoring Systemic Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Evidence by Disease Volume and Timing of Metastasis
Posted innews Oncology Urology

Tailoring Systemic Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Evidence by Disease Volume and Timing of Metastasis

Posted by MedXY By MedXY 12/17/2025
A living network meta-analysis refines treatment strategies for mHSPC subgroups, favoring triplet therapy in synchronous high-volume cases and ARPI doublet therapy in others.
Read More
Five-Year Safety of Avoiding Biopsy After Negative MRI in Prostate Cancer Pathways
Posted innews Radiology Urology

Five-Year Safety of Avoiding Biopsy After Negative MRI in Prostate Cancer Pathways

Posted by MedXY By MedXY 12/17/2025
Long-term data show RAPID MRI-directed pathway safely avoids unnecessary biopsies while maintaining low rates of clinically significant prostate cancer.
Read More
Refining Prostate Cancer Risk Prediction in Men of African Ancestry: Integrating Pathogenic Variants, Polygenic Scores, and Family History
Posted innews Oncology Urology

Refining Prostate Cancer Risk Prediction in Men of African Ancestry: Integrating Pathogenic Variants, Polygenic Scores, and Family History

Posted by MedXY By MedXY 12/17/2025
This study identifies key germline variants and demonstrates how combining genetic data with family history improves personalized prostate cancer risk assessment in men of African ancestry, guiding future screening strategies.
Read More
Personalizing Breast Cancer Screening: Insights from the WISDOM Trial on Risk-Based vs Annual Mammography
Posted innews Oncology

Personalizing Breast Cancer Screening: Insights from the WISDOM Trial on Risk-Based vs Annual Mammography

Posted by MedXY By MedXY 12/17/2025
The WISDOM trial shows risk-based breast cancer screening using genetic and clinical data as a safe alternative to annual mammography, tailoring screening frequency by individual risk without increasing advanced cancer rates.
Read More
Prophylactic Strategies to Prevent Infection in Lower Limb Peripheral Arterial Reconstruction: Evidence and Clinical Implications
Posted inCardiology Infectious Diseases news

Prophylactic Strategies to Prevent Infection in Lower Limb Peripheral Arterial Reconstruction: Evidence and Clinical Implications

Posted by MedXY By MedXY 12/17/2025
Cochrane review shows prophylactic antibiotics may reduce SSI risk in peripheral arterial reconstruction; closed incision negative pressure therapy offers possible benefit but evidence is low.
Read More
Chemoendocrine Therapy Linked to Greater Cognitive Decline in Breast Cancer Patients, Regardless of Menopausal Status
Posted inNeurology news Oncology

Chemoendocrine Therapy Linked to Greater Cognitive Decline in Breast Cancer Patients, Regardless of Menopausal Status

Posted by MedXY By MedXY 12/17/2025
A secondary analysis of the RxPONDER trial finds chemoendocrine therapy causes more lasting cognitive impairment than endocrine therapy alone in both pre- and postmenopausal women.
Read More
Biofeedback vs Respiratory Retraining: No Significant Difference in Inducible Laryngeal Obstruction Relief
Posted innews Otorhinolaryngology Respiratory

Biofeedback vs Respiratory Retraining: No Significant Difference in Inducible Laryngeal Obstruction Relief

Posted by MedXY By MedXY 12/17/2025
A pilot trial finds biofeedback and respiratory retraining equally effective for inducible laryngeal obstruction, offering clinicians flexible, patient-tailored options.
Read More
Elevated Serotonin Release in Schizophrenia: New Insights Into Negative Symptom Pathophysiology
Posted inNeurology news Psychiatry

Elevated Serotonin Release in Schizophrenia: New Insights Into Negative Symptom Pathophysiology

Posted by MedXY By MedXY 12/17/2025
A PET imaging study reveals increased frontal serotonin release in schizophrenia, particularly in deficit type, tied to worse negative symptoms.
Read More
Combined Cardiorespiratory and Resistance Training After Stroke: Small Gains, Big Questions
Posted inCardiology Neurology news

Combined Cardiorespiratory and Resistance Training After Stroke: Small Gains, Big Questions

Posted by MedXY By MedXY 12/17/2025
Evidence suggests combined aerobic and strength training post-stroke yields modest improvements in fitness and function but uncertain long-term benefits.
Read More
Do Behavioural, Self-Management, and Service Delivery Models Improve Outcomes in Adults with Epilepsy?
Posted inNeurology news

Do Behavioural, Self-Management, and Service Delivery Models Improve Outcomes in Adults with Epilepsy?

Posted by MedXY By MedXY 12/17/2025
A Cochrane review finds limited and low- to moderate-certainty evidence that behavioural, self-management, or service delivery interventions improve seizure control or quality of life in adults with epilepsy.
Read More
Omega-3 Fatty Acids Show Limited Benefits for Diabetic Peripheral Neuropathy
Posted inDiabetes & Endocrinology Neurology news

Omega-3 Fatty Acids Show Limited Benefits for Diabetic Peripheral Neuropathy

Posted by MedXY By MedXY 12/17/2025
Current evidence suggests minimal impact of omega-3 supplementation on neuropathy symptoms or quality of life in adults with diabetes.
Read More
Progestagens Show Promise for Pain Relief in Endometriosis, With Nuanced Efficacy Across Comparators
Posted innews

Progestagens Show Promise for Pain Relief in Endometriosis, With Nuanced Efficacy Across Comparators

Posted by MedXY By MedXY 12/17/2025
Oral progestagens likely reduce overall pain and dysmenorrhoea in endometriosis, but comparative benefits over other hormonal treatments remain uncertain.
Read More
Rare but High-Risk: New-Onset RBBB After TAVR Strongly Linked to Pacemaker Need
Posted inCardiology news

Rare but High-Risk: New-Onset RBBB After TAVR Strongly Linked to Pacemaker Need

Posted by MedXY By MedXY 12/17/2025
New-onset right bundle branch block after TAVR is rare but carries a high risk of requiring permanent pacing within one week.
Read More
Prophylactic Pacemakers After TAVR: Low Pacing Burden Raises Questions on Routine Use
Posted inCardiology news

Prophylactic Pacemakers After TAVR: Low Pacing Burden Raises Questions on Routine Use

Posted by MedXY By MedXY 12/17/2025
One-fourth of TAVR patients receive prophylactic pacemakers, but most have minimal pacing needs at 30 days.
Read More
PROMOTE Study Validates Algorithm for Conduction Disturbance Management After TAVR
Posted inCardiology news

PROMOTE Study Validates Algorithm for Conduction Disturbance Management After TAVR

Posted by MedXY By MedXY 12/17/2025
A prospective multicenter study confirms that a prespecified algorithm for conduction disturbance management after TAVR is safe, with low sudden cardiac death risk but persistent high pacemaker rates.
Read More
Distinct Mechanisms Drive Early and Delayed Heart Block After TAVR: Insights from Boston Cohort Study
Posted inCardiology news

Distinct Mechanisms Drive Early and Delayed Heart Block After TAVR: Insights from Boston Cohort Study

Posted by MedXY By MedXY 12/17/2025
Prospective cohort study reveals AV nodal versus infranodal conduction patterns underpinning timing of heart block after TAVR.
Read More
Cryotherapy After Total Knee Replacement: Limited Evidence for Modest Benefits
Posted innews Orthopedics

Cryotherapy After Total Knee Replacement: Limited Evidence for Modest Benefits

Posted by MedXY By MedXY 12/16/2025
Low-certainty evidence suggests cryotherapy may slightly reduce blood loss, pain, and swelling after total knee replacement, but clinical relevance remains uncertain.
Read More
Rethinking Oxygen Strategies for Preterm Infant Resuscitation: Evidence from TORPIDO, IPD-MA, and DCC Trials
Posted inCritical Care news Pediatrics

Rethinking Oxygen Strategies for Preterm Infant Resuscitation: Evidence from TORPIDO, IPD-MA, and DCC Trials

Posted by MedXY By MedXY 12/16/2025
Recent trials and meta-analyses challenge assumptions about optimal initial oxygen levels for preterm resuscitation.
Read More
Broad Genetic Testing Reveals Hidden Breast Cancer Risk in Women Without Family History
Posted innews Oncology

Broad Genetic Testing Reveals Hidden Breast Cancer Risk in Women Without Family History

Posted by MedXY By MedXY 12/16/2025
The WISDOM trial found that 3.1% of women without breast cancer carried pathogenic variants in key susceptibility genes, many outside existing testing guidelines.
Read More
Progestagens Show Moderate Efficacy for Endometriosis Pain, But Evidence Variability Limits Clinical Certainty
Posted innews OB/GYN & Women's Health

Progestagens Show Moderate Efficacy for Endometriosis Pain, But Evidence Variability Limits Clinical Certainty

Posted by MedXY By MedXY 12/16/2025
Oral progestagens reduce overall pain and dysmenorrhoea in endometriosis, but comparative benefits over other hormonal therapies remain uncertain.
Read More

Posts pagination

Previous page 1 … 118 119 120 121 122 … 273 Next page
  • Navigating Complex Decisions: Physician Strategies in Setting Stroke Care Goals for Patients with Preexisting Disability or Dementia
  • Influence of Parity on Cognitive Decline and Hippocampal Atrophy in Amyloid-Positive Postmenopausal Women
  • Long-Term Mortality, Cognition, and Quality of Life After Chronic Subdural Hematoma Surgery: A Comprehensive Review
  • Impact of Constitutively Active TSH Receptor Mutations on Craniofacial and Bone Morphology in Hyperthyroid Mouse Models
  • Gender Differences in Hypoglycaemia Among Type 1 and Insulin-Treated Type 2 Diabetes: Insights from the Hypo-METRICS Study
Post You Might Like
Posted inInternal Medicine Neurology news
Navigating Complex Decisions: Physician Strategies in Setting Stroke Care Goals for Patients with Preexisting Disability or Dementia
Posted by MedXY By MedXY 06/25/2026
Posted inNeurology news OB/GYN & Women’s Health
Influence of Parity on Cognitive Decline and Hippocampal Atrophy in Amyloid-Positive Postmenopausal Women
Posted by MedXY By MedXY 06/25/2026
Posted inClinical Updates news
Long-Term Mortality, Cognition, and Quality of Life After Chronic Subdural Hematoma Surgery: A Comprehensive Review
Posted by MedXY By MedXY 06/24/2026
Posted inDiabetes & Endocrinology news Orthopedics
Impact of Constitutively Active TSH Receptor Mutations on Craniofacial and Bone Morphology in Hyperthyroid Mouse Models
Posted by MedXY By MedXY 06/24/2026
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prostate cancer public health quality of life randomized clinical trial randomized trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in